Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies
- DOI
- 10.1016/j.ejca.2026.117817
- Published
- 2026-12
- Container
- European Journal of Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2026.117817,
title = {Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies},
author = {Lisa Wein and Carolin Ertl and Kai Rejeski and Richard David-Rus and Mingzi Kong-Bild and Rebecca Pusl and Lisa Frölich and Dirk Tomsitz and Louisa von Baumgarten and Marion Subklewe and Lucie Heinzerling},
year = {2026},
journal = {European Journal of Cancer},
doi = {10.1016/j.ejca.2026.117817},
url = {https://doi.org/10.1016/j.ejca.2026.117817}
}RIS
TY - JOUR TI - Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies AU - Lisa Wein AU - Carolin Ertl AU - Kai Rejeski AU - Richard David-Rus AU - Mingzi Kong-Bild AU - Rebecca Pusl AU - Lisa Frölich AU - Dirk Tomsitz AU - Louisa von Baumgarten AU - Marion Subklewe AU - Lucie Heinzerling PY - 2026 JO - European Journal of Cancer DO - 10.1016/j.ejca.2026.117817 UR - https://doi.org/10.1016/j.ejca.2026.117817 ER -
APA
Wein, L., Ertl, C., Rejeski, K., David-Rus, R., Kong-Bild, M., Pusl, R., Frölich, L., Tomsitz, D., Baumgarten, L. V., Subklewe, M., & Heinzerling, L. (2026). Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117817
Source records
- crossref · retrieved 2026-11-08T18:12:38.591Z